BioMarin’s new CEO inherits a profitable company, a pioneering gene therapy, and a brewing activist challenge

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a close look at…
Click here to view original post